1-7 of 7
Stefan Miltenyi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zamtocabtagene autoleucel, a tandem CD20-CD19 directed CAR-T cell therapy as second-line treatment for Relapsed/Refractory large B-cell lymphoma: primary analysis of the randomized, pivotal DALY 2-EU study.

Free
Peter Borchmann, Tom Van Meerten, Pierre Bories, Peter Dreger, Laszlo Gopsca, Pim Mutsaers, Matthias Edinger, Arpad Illes, Bastian von Tresckow, Peter Neumeister, Normann Steiner, Ulrich Jaeger, Ana Triguero Moreno, Laimonas Griškevičius, Gloria Iacoboni, François Lemonnier, Jaap Van Doesum, Nirav Shah, Rimas Orentas, Stefan Miltenyi, Toon Overstijns, Iris Bürger, Gregor Zadoyan, Corinne Brillant, Pearl van Heteren, Silke Holtkamp, Peter Vandenberghe
Journal: Blood
Blood (2025) 146 (Supplement 1): 669.
https://doi.org/10.1182/blood-2025-669
Published: 2025
Journal Articles

Safety and preliminary efficacy of anti-CD19 CAR T cells zorpocabtagene-autoleucel in systemic autoimmune diseases: Final analysis of the castle trial

Free
Fabian Müller, Melanie Hagen, Silvia Spoerl, Andreas Wirsching, Soraya Kharboutli, Sascha Kretschmann, Koray Tascilar, Jule Taubmann, Laura Bucci, Maria Raimondo, Christina Bergmann, Carlo Tur, Luis Muñoz, Ingrid Vasova, Armin Gerbitz, Bernd Spriewald, Diana Ginnarelli, Franco Locatelli, Maria-Antonietta D'Agostino, Linda Hanssen, Aline Bozec, Ricardo Grieshaber-Boyer, Stefan Miltenyi, Michael Aigner, Simon Voelkl, Georg Schett, Andreas Mackensen
Journal: Blood
Blood (2025) 146 (Supplement 1): 2380.
https://doi.org/10.1182/blood-2025-2380
Published: 2025
Journal Articles

Characterization and T-Cell Repertoire of MB-CART2019.1 (Zamtocabtagene autoleucel) - Data from the Phase I Trial in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Free
Tatjana Holzer, Stefanie Biedermann, Inga Herfort, Birte Friedrichs, Silke Holtkamp, Linda Hanssens, Mario Assenmacher, Ulf Bethke, Dina Schneider, Stefan Miltenyi, Toon Overstijns, Christoph Schmid, Francis A. Ayuk, Christoph Scheid, Anja Jühling, Udo Holtick, Philipp Gödel, Peter Borchmann, Iris Bürger
Journal: Blood
Blood (2022) 140 (Supplement 1): 4581–4583.
https://doi.org/10.1182/blood-2022-164597
Published: 2022
Journal Articles

Phase I Trial of MB-CART2019.1, a Novel CD20 and CD19 Targeting Tandem Chimeric Antigen Receptor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Free
Peter Borchmann, Anja Jühling, Philipp Gödel, Hyatt Balke-Want, Christoph Schmid, Francis A. Ayuk, Silke Holtkamp, Liane Preussner, Gregor Zadoyan, Linda Hanssens, Andrew Kaiser, Marion Jurk, Iris Bürger, Dina Schneider, Boro Dropulic, Toon Overstijns, Christof Scheid, MD, Udo Holtick, Stefan Miltenyi, Michael Hallek
Journal: Blood
Blood (2020) 136 (Supplement 1): 48.
https://doi.org/10.1182/blood-2020-136067
Published: 2020
Journal Articles

Automated Generation of Antigen-Specific T Cells for Adoptive T Cell Therapy.

Free
Melanie Fahrendorff, Nanette von Oppen, Georg Rauser, Mario Assenmacher, Juergen Schmitz, Martin Biehl, Stefan Miltenyi
Journal: Blood
Blood (2010) 116 (21): 1177.
https://doi.org/10.1182/blood.V116.21.1177.1177
Published: 2010
Journal Articles

Next Level of Automated Cell Processing System for Flexible Manufacturing of Cellular Products.

Free
Gerd Hempel, Stefan Miltenyi, Volker Huppert
Journal: Blood
Blood (2010) 116 (21): 1186.
https://doi.org/10.1182/blood.V116.21.1186.1186
Published: 2010
Journal Articles

Cell Separation System for Fully Automated Clinical Scale Separation of CD133+ Cells From Bone Marrow Aspirates.

Free
Mike Essl, Juliane Stuth, Volker Huppert, Dirk Balshüsemann, Petra Bauer, Stefan Miltenyi
Journal: Blood
Blood (2010) 116 (21): 1188.
https://doi.org/10.1182/blood.V116.21.1188.1188
Published: 2010